1:55PM - 2:00PM
Thursday, 13th February
Novartis Lecture Theatre
2:00PM - 3:00PM
Thursday, 13th February
Novartis Lecture Theatre
3:00PM - 4:00PM
Thursday, 13th February
Exhibition Hall
4:00PM - 6:00PM
Thursday, 13th February
Novartis Lecture Theatre
6:20PM - 7:30PM
Thursday, 13th February
Seagrass Lawn
7:30PM - 10:00PM
Thursday, 13th February
Exhibition Hall
-
Gamma camera imaging of small animals injected with 177Lu-MDP, 177Lu-PYP and 177Lu-HA with potentials to be used for the treatment of bone cancer and rheumatoid arthritis -
Imtiaz A Abbasi
-
Inhibition of Tumour Angiogenesis as a means to reduce cancer growth by novel Benzoaxines -
Sara Al-Rawi
-
Identification of Chromosomal Aberrations Using Fluorescence In Situ Hybridization (Fish) And Drug Metabolizing Gene Polymorphism (Gst, Cyp) In Prostate Cancer Patients of South Indian Region, India. -
karthick kumar alagamuthu
-
Molecular Evaluation of Anti-Proliferative Effect of (Cichorium endivia, L.) Extracts On the Growth of Hepatocellular Carcinoma -
Ali Alshehri
-
POT1 mutations predispose to familial melanoma -
Lauren G Aoude
-
IT’S A HIT: THE ACRF DRUG DISCOVERY CENTRE -
Greg M Arndt
-
Induction of Apoptosis by Fucoidan in Human Acute Promyelocytic Leukaemia cells -
Farzaneh F Atashrazm
-
Cyclin-dependent kinase inhibitor, Dinaciclib induces anti-tumour activity of mixed-lineage leukemia-AF9 surpassing known targeted therapies for this disease. -
Adele J Baker
-
Autophagy-related genes act as tumour suppressors in cooperation with oncogenic Ras to promote epithelial tumourigenesis in Drosophila -
Sangita Banerjee
-
The oncofetal protein, Insulin-like growth factor 2 mRNA-binding protein 1 has Increased DNA Copy Number, mRNA, and Protein Expression in High-risk Neuroblastoma -
Jessica Bell
-
Role of the transcription factor Id4 in the developing mammary gland -
Sarah Best
-
Characterisation of ADAMTS15: a potential tumour suppressor gene in Prostate cancer -
Marley J Binder
-
Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis. -
Gavin D Brooks
-
Using a novel mouse model of colitis to study the impact of different oncogenic mutations on intestinal tumourigenesis -
Michael Buchert
-
NFKBIA (IkBα) mediates prostate cancer cell death induced by combination treatment with vorinostat and bicalutamide -
Lisa M Butler
-
Drugging the undruggable in the clinic: a Phase I trial for RNA Polymerase I inhibitor CX-5461 in haematological malignancies -
Don P Cameron
-
Genome wide RNAi screen to identify regulators of the oncoprotein LMO4. -
Bianca Capaldo
-
Arsenic-induced differential protein changes in rat uroepithelial cells -
Chee-Yin Chai
-
The Ubiquitin Ligase Siah is a novel regulator of Zeb1 in Breast Cancer -
Anna Chen
-
Differential expression analysis of RNA-seq data using edgeR and limma -
Yunshun Chen
-
Profiling the evolution of malignant melanoma -
Vincent D Corbin
-
DNA based immunotherapy in triple negative metastatic breast cancer -
Ryan Cross
-
Mutations in GRIN2A correlate with reduced survival of melanoma patients -
Stacey N D'mello
-
Continuous low-dose estrogen supplementation can sustain MCF7 tumour growth with no estrogen-related toxicity -
Genevieve Dall
-
The development of novel peptide based drugs for the treatment of sonic hedgehog dependent medulloblastoma and other cancers. -
Peter B Dallas
-
A transcriptional role for cohesin in breast cancer -
Tanushree Dasgupta
-
Snail2 inhibits terminal differentiation by directly down-regulating the serine proteinase, matriptase-1 -
Naomi C Delic
-
Elucidating the mechanism by which novel anti-tropomyosin compounds induce neuroblastoma cell death -
Melissa Desouza
-
Combined inhibition of ribosome biogenesis and ribosome function cooperate to extend survival in MYC-driven B-cell lymphoma -
Jennifer R Devlin
-
GPR84 drives beta-catenin expression in leukaemic stem cells to maintain acute myeloid leukaemia -
Philipp A Dietrich
-
PG545, a heparan sulfate mimetic, targets the tumour microenvironment to potently inhibit solid tumour growth and metastasis, alone and in combination with chemotherapy, in models of pancreatic and ovarian cancer. -
Keith Dredge
-
How do cancer cells become aneuploid? -
Pascal HG Duijf
-
The role of myoepithelial proteins in blocking breast cancer invasion -
Hendrika M Duivenvoorden
-
Immune cell infiltration is associated with resistance to endocrine therapy in oestrogen receptor positive breast cancers -
Anita K Dunbier
-
Adoptive immunotherapy utilising chimeric receptors identified using a DNA library approach -
Connie PM Duong
-
Functional studies of cysteine cathepsin activity in breast cancer metastasis -
Laura E Edgington
-
The role of Deubiquitinating Enzymes in the TGFB pathway -
Pieter Eichhorn
-
Histological and molecular profiling of dividing cells in cancer using EdU -
Berwini Endaya
-
TRAF2 regulates canonical and non canonical NFĸB pathways to inhibit cell death and inflammation in skin. -
Nima Etemadi
-
Cell death mediates perinatal lethality in RIPK1 knockout mice -
Joseph M Evans
-
Targeting epigenetically driven leukaemias through inhibition of the acetyltransferase monocytic leukaemia zinc finger protein (MOZ) -
Hendrik Falk
-
A genome-wide screen for novel genes involved in sensitisation to histone deacetylase inhibitors -
Katrina J Falkenberg
-
Highly metastatic MDA-MB-231 breast tumour cells: altered migratory potential and sensitivity to glucocorticoids? -
Ebony R Fietz
-
Yes-associated protein (YAP) regulates transcriptional coactivator with PDZ-binding motif (TAZ) abundance to rescue proliferation of liver progenitor cells. -
Megan Finch
-
Localized synchrotron radiation affects serum cytokine levels and modulates gene expression in irradiated mouse skin and in skin distant from the irradiated site. -
Helen B Forrester
-
Elf5: double-edged sword for breast cancer metastasis -
David Gallego Ortega
-
E6AP acts through E2F1 to suppress the INK4/ARF locus: implications for NSCLC -
Cristina Gamell
-
Molecular Analysis of Circulating Tumour Cells (CTCs) from the Blood of Patients with Colorectal Cancer (CRC) detected with the CellSearch System -
Christin Gasch
-
A PR55a-containing PP2A complex positively regulates Fra-1/c-Jun function in tumour cells -
Omer Gilan
-
The asymmetric cell division regulator GPSM2 controls mammary progenitor activity and breast cancer progression. -
Nathan Godde
-
Oncogenic H-Ras induced epithelial-mesenchymal transition (EMT) of Madin-Darby canine kidney (MDCK) cells: functional insights into released extracellular vesicles -
Shashi Gopal
-
REGULATION OF PD-L1 EXPRESSION IN HUMAN MELANOMA BY NF-kB -
Kavitha Gowrishankar
-
Retinoic Acid Receptor (RAR) agonists maintain bi-potency of mesenchymal progenitor cells in vitro -
Alanna C Green
-
The oncogenic functionality of JAK2 and PD-L1 to Eµ-Myc lymphoma -
Gareth Gregory
-
Efficacy of allosteric MK2 inhibitors as single agents in glioblastoma cells -
Fadi Gurgis
-
Patterns of care for women with invasive endometrial cancer – results from the population-based Australian National Endometrial Cancer study -
Alison M Hadley
-
Zeb2 Drives T-cell Lymphoblastic Leukemia Development Via Altered IL-7 Receptor Signaling And Enhanced Tumor-Initiating Potential -
Jody Haigh
-
Targeted Genome Sequencing Reveals Mitochondrial Mutations Driving Metabolic Adaptation in Pancreatic Cancer. -
Rae-Anne Hardie
-
Heterozygous expression of an oncogenic Pik3ca mutation during murine development results in fatal embryonic and extraembryonic defects -
Lauren M Hare
-
Inhibition of Cancer Invasion by PAI-2/SerpinB2, a Specific Regulator of Urokinase Plasminogen Activator -
Nathanial L Harris
-
Exploring Mdmx Inhibition as a novel Breast Cancer Therapy -
Sue Haupt
-
A role for E6AP in cellular senescence by regulating the p53/INK4-ARF pathways -
Ygal Haupt
-
Investigation of tryptophan metabolism in various human breast cancer subtypes -
Benjamin R Heng
-
Improving targeted therapy in oncogene expressing High-Grade Serous Ovarian Cancer using novel xenografts -
Valerie Heong
-
Characterising mechanisms of apoptosis induction by BET-bromodomain inhibition in aggressive Myc-driven lymphoma -
Simon Hogg
-
Combined Wnt/β-catenin, Met and CXCL12/CXCR4 Signals Characterize Basal Breast Cancer and Predicts Disease Outcome -
Jane D Holland
-
Enriched expression of the nuclear receptor PXR (NR1I2) drives colon Tumour-Initiating Cell resistance to chemotherapy. -
Fred Hollande
-
Nanotechnology to Fight Ovarian Cancer (Synthesis to in-vivo Study) -
Lubna Hossain
-
Dual targeting of hypoxia and homologous recombination repair defects for cancer therapy -
Francis W Hunter
-
Glaucarubinone Inhibited Colorectal Cancer Growth by Down-Regulation of p21- Activated Kinase 1. -
Nhi Huynh
-
Defining the Role of E3 Ubiquitin Ligase UBR5 in Cancer Through Substrate Identification -
Mary Iconomou
-
Gain-of-function Lyn induces anemia – appropriate Lyn activity is essential for normal erythropoiesis and Epo-receptor signaling. -
Evan Ingley
-
The interaction of cisplatin and related novel drug analogues with DNA containing telomeric repeat sequences -
Ben Johnson
-
Modeling myelodysplastic syndromes in mice by altered Hoxa1 spliceform expression -
Chacko Joseph
-
INTRAVITAL IMAGING REVEALS TUMOUR-ASSOCIATED macrophages as targets of bisphosphonateS IN VIVO -
Simon Junankar
-
Investigating the role of Pim-1 kinase in breast cancer brain metastasis -
Lara Jupp
-
Amino acids increase RNA polymerase I transcription through mTORC1 and MYC signaling pathways -
Jian Kang
-
Quantitative Analysis and Mathematical Modeling of the Effects of Cytokine Signalling on Epithelial Cells -
Shabnam Khatibi
-
Evaluation of Novel HDAC Inhibitors against Mouse and Human Brain Metastatic Breast Cancer In Vitro and In Vivo -
Soo Hyun Kim
-
The NSAID sulindac activates pro-inflammatory NF-kB and AP-1 signalling but also causes apoptosis of colon cancer cells. -
Maija RJ Kohonen-Corish
-
ALLOCATE: sorting ovarian cancer patients into treatment arms based on molecular and genetic make up of their tumours. -
Olga Kondrashova
-
Tumor Initiating Cells and Chemoresistance in Colorectal Cancer -
E. Louise Lagerqvist
-
Understanding the role of the Bcl-2 family member Bcl-G in inflammation-associated colon cancer -
Nga Lam
-
Defining the role of ZEB1 in the pathogenesis of non-small cell lung cancer (NSCLC) using immortalized human bronchial epithelial cells (HBECs) -
Jill E Larsen
-
Chronic stress promotes lymph node metastasis through beta-adrenergic regulation of lymphangiogenesis -
Caroline P Le
-
TIE2 expressing monocytes: Investigating their protumoural and prometastatic activities -
Shannon Jing Yi Lee
-
Exome sequencing reveals Bcl6 co-repressor (Bcor) as a frequently mutated tumor suppressor gene in Eμ-Myc lymphoma -
Marcus Lefebure
-
BL-011256 is a novel VEGFR3 selective inhibitor, which suppresses tumour lymphatics and lymph node metastasis in an animal model of melanoma -
Annabell Leske
-
Targeting a novel epigenetic oncogene required for the maintenance of acute myeloid leukaemic stem cells -
Halina Leung
-
Sorting nexin 5 (SNX5) is a regulator of the macropinocytic pathway. -
Jet Phey Lim
-
Towards a structural understanding of the cell polarity regulator and tumour suppressor protein, Scribble -
Krystle Lim
-
POLO-LIKE KINASE 1 AS A BIOMARKER IN RECTAL CANCER -
-
Circulating microRNAs associated with chemotherapy outcome of prostate cancer -
Hui-Ming Lin
-
Methods and data analysis tools for sequencing ribosome protected mRNA fragments -
Leah Alcock